Our results showed that the expression levels of FBXO22, HIF-1α, and VEGFA in high-grade gliomas were much higher than those in low-grade gliomas, while the expression level of VHL in high-grade gliomas was much lower than that in low-grade gliomas (Fig. 7A). This evidence concerns the gene VEGFA and central nervous system cancer.